Clinical Trial Update: Treatment of Psychosis and Agitation in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting results for treating psychosis and agitation in Alzheimer's disease. The study is completed and results were posted on 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Alzheimer's Disease, Psychosis | Phase 2 | Status: COMPLETED | Results posted: 2021-08-16